New Study Confirms CorKnot® Reduces Infection Risks in Cardiac Surgery
At Minogue Medical, we are dedicated to bringing innovative solutions to the medical field that enhance patient outcomes and optimize surgical procedures. One such groundbreaking device, the CorKnot® Automated Fastener, has once again proven its clinical value.
A recent study published in The European Journal of Cardio-Thoracic Surgery reveals that CorKnot significantly reduces the risk of infections, including infective endocarditis, compared to traditional hand-tied sutures. These findings reinforce the device’s role in improving not only surgical precision but also long-term patient safety.
Key Findings from the Study
The study evaluated 1,405 patients across three surgical access methods—open, minimally invasive, and robotic-assisted. The results were clear:
- Automated titanium fasteners, like those used in the CorKnot device, were associated with a significantly lower risk of infective endocarditis during follow-up compared to traditional sutures.
- This reduction in infection risk not only enhances patient safety but also decreases the likelihood of costly and complex reinterventions.
These results further validate CorKnot’s ability to deliver reliable, consistent suture fixation while minimizing the risk of complications.
CorKnot: Innovation That Drives Better Outcomes
The CorKnot device was designed to improve cardiac surgical procedures by:
- Ensuring precise and secure suture fastening.
- Reducing variability in knot-tying, which can occur with manual techniques.
- Saving valuable operating room time, benefiting both patients and surgical teams.
This latest research demonstrates that the benefits extend beyond the operating room, offering long-term protection against serious complications like infections.
Infographic: Key Insights from the Study
To make it easier to understand the impact of CorKnot, we’ve created a concise infographic highlighting the study’s key findings. This visual resource provides a quick snapshot of how CorKnot is reshaping cardiac surgery and improving patient care.
Amila Kahrovic, Harald Herkner, Philipp Angleitner, Paul Werner, Alfred Kocher, Marek Ehrlich, Dominik Wiedemann, Guenther Laufer, Paul Simon, Martin Andreas, Automated titanium fastener for surgical aortic valve replacement—preventive role for infective endocarditis?, European Journal of Cardio-Thoracic Surgery, Volume 65, Issue 6, June 2024, ezae236, https://doi.org/10.1093/ejcts/ezae236
Click Here to Read the Full Research Paper
What This Means for Your Practice
For surgeons and healthcare providers, these findings underscore the importance of adopting innovative technologies that prioritize patient safety and reduce complications. By integrating CorKnot into your practice, you can:
- Enhance patient outcomes by reducing infection risks.
- Streamline surgical workflows with reliable and efficient suture fixation.
- Lower the total cost of care by minimizing post-operative complications and reinterventions.
Learn More
We’re excited to share this breakthrough research and discuss how CorKnot can support your commitment to patient safety and surgical excellence.
📖 Access the full study in The European Journal of Cardio-Thoracic Surgery: Read the Study
📊 Explore our infographic to dive deeper into the findings: View the Infographic in this article above.
💬 Let’s Connect: Contact us today to learn more about CorKnot and how it can elevate your surgical outcomes.
